glp-1 weight loss drug news today The next generation of drugs obesity drug news today glp-1

The present review ultimately weighs early concerns against increasingly consistent evidence that GLP-1 RA use does not raise overall cancer risk, clarifies that breast cancer risk appears neutral, and further highlights key mechanisms, such as the reduction of hyperinsulinemia and immune-microenvironment modulation, through which these drugs may improve rather than exacerbate malignancy outcomes

Chem Biol Interact

Otero-Martinez, A

Bupropion can cause some people who were manic or depressed in the past to become manic or depressed again

Did my first injection on July 6

Liraglutide has a proven efficacy in improving glycaemic control in patients with type 2 diabetes mellitus